Clinical Trials Logo

Insulin Resistance clinical trials

View clinical trials related to Insulin Resistance.

Filter by:

NCT ID: NCT02068144 Completed - Insulin Resistance Clinical Trials

The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans

Start date: February 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the health benefits of cranberry extract in people who are at risk for diabetes and heart problems.

NCT ID: NCT02062307 Completed - Insulin Resistance Clinical Trials

Bone Mineral Markers in Hypogonadism

Start date: August 2012
Phase: N/A
Study type: Observational

The aim of this study is to investigate the markers of bone mineral metabolism in an unconfounded group of patients with hypogonadism and to search for a relationship between endothelial dysfunction and insulin resistance.

NCT ID: NCT02060240 Completed - Obesity Clinical Trials

Physical Activity and Obesity

Start date: February 2014
Phase: N/A
Study type: Interventional

The purpose of the study is to see if a twelve-week exercise intervention in overweight or obese subjects with pre-diabetes or early disease course type 2 diabetes can lead to improved skeletal muscle capillary blood flow by improving substances that dilate blood vessels and result in improved insulin sensitivity.

NCT ID: NCT02058914 Completed - Insulin Sensitivity Clinical Trials

Effects of Sugar Sweetened Beverage on Metabolic Health in Male and Female Adolescents

adol
Start date: September 2011
Phase: N/A
Study type: Interventional

We examined the effects of short-term (2-wk) consumption of HF- and HG-sweetened beverages in adolescents (15-20 yr of age) on insulin sensitivity, insulin secretion, insulin clearance, triacylglycerol (TAG), and cholesterol concentrations.

NCT ID: NCT02045290 Completed - Type 1 Diabetes Clinical Trials

Insulin Clamp Ancillary Study for Assessment of Insulin Resistance

Start date: January 2014
Phase: Phase 3
Study type: Interventional

Insulin Clamp Ancillary study for Assessment of Insulin Resistance will be conducted as a sub-study to the main protocol, Metformin Therapy for Overweight Adolescents With Type 1 Diabetes (NCT01881828). The purpose of this ancillary study is to assess if metformin will improve tissue-specific insulin resistance (IR) in type 1 diabetes using a hyperinsulinemic euglycemic clamp; a 3-month randomized trial comparing metformin versus placebo in 12 to <20 year olds with BMI >85th percentile ( total daily insulin dose >0.7 units/kg, and HbA1c 7.0%-9.9%).

NCT ID: NCT02043405 Completed - Diabetes Clinical Trials

Weight Loss and/or Exercise Training to Discover Muscle Lipids Related to Insulin Sensitivity

Start date: January 2014
Phase: N/A
Study type: Interventional

The investigators will use exercise training and weight loss to discover localized lipid species related to diabetes risk in people.

NCT ID: NCT02039934 Completed - Type 2 Diabetes Clinical Trials

Effect of High-intensity Low-volume Training on Insulin Sensitivity in Type 2 Diabetes

HIT
Start date: July 2014
Phase: N/A
Study type: Interventional

High intensity interval training is applied for several diseases. Hypothesis: High intensity interval training improves insulin sensitivity in patients with type 2 diabetes.

NCT ID: NCT02039141 Completed - Obesity Clinical Trials

Diabetes Prevention Program for Obese Latino Youth

ELSC
Start date: April 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effects of 12 week lifestyle intervention on diabetes risk in obese Latino adolescents.

NCT ID: NCT02035592 Completed - Insulin Resistance Clinical Trials

The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)

CIRCLES
Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the dose-dependent impact of 6 month freeze-dried blueberry powder intake on insulin sensitivity and resistance, cardiovascular disease risk factors, and lung and cognitive function in overweight and obese participants with metabolic syndrome. We will also examine acute post-prandial effects of blueberry intake (at baseline and at 6-months).

NCT ID: NCT02034331 Completed - Insulin Resistance Clinical Trials

IR and Microvascular Blood Flow in SCI

Start date: December 2012
Phase: N/A
Study type: Interventional

Persons with spinal cord injury (SCI) are at an increased risk for metabolic disorders, including that of insulin resistance. As a result of neurological injury, they often have impaired mechanisms that regulate blood vessel function below the level of injury. Insulin, which facilitates the transport of glucose into muscle cells, is also capable of regulating skin blood flow, with insulin resistance reducing perfusion. Although beyond the scope of this proposal, the possibility exists that impaired microvascular skin blood flow responses due to insulin may further predispose to ischemia of the skin at pressure points of bony prominence. This perturbed cutaneous vascular response may place persons with SCI at risk for the development and poor healing of pressure ulcers due to microvascular dysfunction secondary to neurologic and metabolic disorders. Primary Aim: To determine the association between systemic insulin sensitivity and insulin-mediated vasodilatation below the neurological level of injury. We hypothesize that individuals with systemic insulin sensitivity compared to those with insulin resistance will have greater insulin-mediated vasodilatation and an associated proportional increase in cutaneous blood perfusion. Thus, intact and appropriate endothelial-mediated regulation by insulin will be operative despite sub-lesional neurological impairment in insulin sensitive individuals with SCI. However, because of the absence of the SNS-mediated insulin action on the microvasculature (i.e., insulin-mediated sympathetic withdrawal), it is being hypothesized that the vasodilatory response to iontophoresis with insulin in insulin sensitive subjects with SCI will be less than that observed in neurologically intact controls with insulin sensitivity. Secondary Aim: To compare peak microvascular perfusion responses to endothelial-dependent vasodilatation by iontophoresis with acetylcholine to insulin. We hypothesize that the peak blood perfusion responses to iontophoresis with insulin will be comparable in magnitude to that of acetylcholine in individuals with greater systemic insulin sensitivity. This will be in contrast to individuals with systemic insulin resistance who will demonstrate a diminished response to iontophoresis with insulin when compared to that of acetylcholine. Because of SNS impairment, the peak vasodilatory response observed to these interventions will be lower in the group with SCI.